First Hawaiian Bank Repligen Corp Transaction History

First Hawaiian Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$140.68 - $188.02 $444,689 - $594,331	-3,161 Closed	0 $0
Q1 2022 Apr 06, 2022	BUY	$161.19 - $257.96 $4,996 - $7,996	31 Added 0.99%	3,161 $595,000
Q4 2021 Jan 12, 2022	BUY	$247.59 - $304.47 $774,956 - $952,991	3,130 New	3,130 $829,000
Q2 2019 Jul 15, 2019	SELL	$54.2 - $85.95 $28,726 - $45,553	-530 Closed	0 $0
Q4 2018 Jan 11, 2019	BUY	$48.26 - $68.88 $25,577 - $36,506	530 New	530 $28,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.